XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2022   72,585,596      
Beginning balance at Dec. 31, 2022 $ 3,091,784 $ 726 $ 1,784,173 $ 1,306,885 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 80,700     80,700  
Other comprehensive income (loss) 323       323
Shares issued under stock-based compensation programs, net (in shares)   503,022      
Shares issued under stock-based compensation programs, net (11,740) $ 5 (11,745)    
Cash dividends declared (36,543)     (36,543)  
Stock-based compensation expense 5,597   5,597    
Forfeiture of restricted stock (in shares)   (1,283)      
Ending balance (in shares) at Mar. 31, 2023   73,087,335      
Ending balance at Mar. 31, 2023 3,130,121 $ 731 1,778,025 1,351,042 323
Beginning balance (in shares) at Dec. 31, 2022   72,585,596      
Beginning balance at Dec. 31, 2022 3,091,784 $ 726 1,784,173 1,306,885 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 281,498        
Other comprehensive income (loss) 91        
Ending balance (in shares) at Sep. 30, 2023   74,662,468      
Ending balance at Sep. 30, 2023 3,292,543 $ 747 1,817,494 1,474,211 91
Beginning balance (in shares) at Mar. 31, 2023   73,087,335      
Beginning balance at Mar. 31, 2023 3,130,121 $ 731 1,778,025 1,351,042 323
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 93,493     93,493  
Other comprehensive income (loss) (233)       (233)
Shares issued under stock-based compensation programs, net (in shares)   1,459,256      
Shares issued under stock-based compensation programs, net 31,332 $ 14 31,318    
Cash dividends declared (36,566)     (36,566)  
Stock-based compensation expense 2,956   2,956    
Forfeiture of restricted stock (in shares)   (2,370)      
Ending balance (in shares) at Jun. 30, 2023   74,544,221      
Ending balance at Jun. 30, 2023 3,221,103 $ 745 1,812,299 1,407,969 90
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 107,305     107,305  
Other comprehensive income (loss) 1       1
Shares issued under stock-based compensation programs, net (in shares)   118,247      
Shares issued under stock-based compensation programs, net 1,220 $ 2 1,218    
Cash dividends declared (41,063)     (41,063)  
Stock-based compensation expense 3,977   3,977    
Ending balance (in shares) at Sep. 30, 2023   74,662,468      
Ending balance at Sep. 30, 2023 $ 3,292,543 $ 747 1,817,494 1,474,211 91
Beginning balance (in shares) at Dec. 31, 2023 74,661,479 74,661,479      
Beginning balance at Dec. 31, 2023 $ 3,377,885 $ 747 1,824,434 1,552,653 51
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 95,819     95,819  
Other comprehensive income (loss) (47)       (47)
Shares issued under stock-based compensation programs, net (in shares)   386,523      
Shares issued under stock-based compensation programs, net (25,626) $ 3 (25,629)    
Cash dividends declared (41,276)     (41,276)  
Stock-based compensation expense 2,632   2,632    
Forfeiture of restricted stock (in shares)   (301)      
Ending balance (in shares) at Mar. 31, 2024   75,047,701      
Ending balance at Mar. 31, 2024 $ 3,409,387 $ 750 1,801,437 1,607,196 4
Beginning balance (in shares) at Dec. 31, 2023 74,661,479 74,661,479      
Beginning balance at Dec. 31, 2023 $ 3,377,885 $ 747 1,824,434 1,552,653 51
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 254,490        
Other comprehensive income (loss) $ (6)        
Ending balance (in shares) at Sep. 30, 2024 100 100      
Ending balance at Sep. 30, 2024 $ 2,922,346 $ 0 1,197,734 1,724,567 45
Beginning balance (in shares) at Mar. 31, 2024   75,047,701      
Beginning balance at Mar. 31, 2024 3,409,387 $ 750 1,801,437 1,607,196 4
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 25,134     25,134  
Other comprehensive income (loss) 20       20
Shares issued under stock-based compensation programs, net (in shares)   1,653      
Shares issued under stock-based compensation programs, net 28   28    
Stock-based compensation expense 173   173    
Effect of merger transaction (in shares)   (75,049,254)      
Effect of Merger transaction (604,654) $ (750) (603,904)    
Ending balance (in shares) at Jun. 30, 2024   100      
Ending balance at Jun. 30, 2024 2,830,088 $ 0 1,197,734 1,632,330 24
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 133,537     133,537 0
Other comprehensive income (loss) 21       21
Cash dividends declared $ (41,300)     (41,300)  
Ending balance (in shares) at Sep. 30, 2024 100 100      
Ending balance at Sep. 30, 2024 $ 2,922,346 $ 0 $ 1,197,734 $ 1,724,567 $ 45